Clinical Trials in Denver

Showing 641-660 of 15,604 trials

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

NCT05868629

This study is a phase IV, pragmatic single-arm prospective, open label study in pediatric (1 years or older) and adult study participants with rare BRAF V600E mutation-positive unresectable or metastatic solid tumors for whom a decision has already been made to be treated with dabrafenib and trametinib, irrespective of the trial participation.

Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

Novartis Pharmaceuticals40 participantsStarted Feb 2024

Torrance, California, United States • Denver, Colorado, United States • Washington D.C., District of Columbia, United States +5 more locations

RECRUITINGPhase 2< 1 mile

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

NCT07146906

The purpose of the study is to assess the effect of zigakibart on IgA nephropathy (IgAN) disease progression.

Immunoglobulin A Nephropathy (IgAN)

Novartis Pharmaceuticals32 participantsStarted Mar 2026

Denver, Colorado, United States • Acworth, Georgia, United States • Edina, Minnesota, United States +5 more locations

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

Find Trials by Condition in Denver

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

SPO2 VALIDATION STUDY - PHILIPS FAST 2025

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

MISHA Post-Market Clinical Study

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

Using Aspirin to Improve Immunological Features of Ovarian Tumors